KCNJ10 and myeloid sarcoma: Alternatively, Kir5.1 upregulation may underlie reduced Kir4.1 function in MS because presence of Kir5.1 subunit confers loss of functional activity to Kir4.1/Kir5.1 channels under oxidative stress (Jin et al., 2012).